Canopy Growth (CGC) lost ~12% on Friday after the Canadian cannabis producer announced financials for Q4 FY23, indicating another quarterly contraction. Read more here.
"The Pharmaceutical Cannabis Report: 2nd Edition" report has been added to ResearchAndMarkets.com's offering. Research on the endocannabinoid system is one of the most promising avenues for new
Shanken News Daily: Exclusive news and research on the wine, spirits and beer business shankennewsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shankennewsdaily.com Daily Mail and Mail on Sunday newspapers.